TickerFacts.

Regencell Bioscience Holdings Ltd (RGC): Operating Income

Annual figures by period end, from SEC filings.

-$3.77M
Year ended 2025-06-30
2019-06-30: -$391.0K2020-06-30: -$812.4K2021-06-30: -$1.38M2022-06-30: -$7.62M2023-06-30: -$6.27M2024-06-30: -$4.74M2025-06-30: -$3.77M-$3.77M
2019-06-30 Operating Income (USD) 2025-06-30
Period endedOperating IncomeChange YoYSource filing
2025-06-30-$3.77Mn/m2025-10-31, From 2024-07-01
2024-06-30-$4.74Mn/m2025-10-31, From 2023-07-01
2023-06-30-$6.27Mn/m2025-10-31, From 2022-07-01
2022-06-30-$7.62Mn/m2024-10-25, From 2021-07-01
2021-06-30-$1.38Mn/m2023-10-27, From 2020-07-01
2020-06-30-$812.4Kn/m2022-10-31, From 2019-07-01
2019-06-30-$391.0Kn/a2021-10-29, From 2018-07-01

Operating Income at similar companies

Companies with the same SEC industry code (Medicinal Chemicals & Botanical Products), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating IncomeChange YoY
Regencell Bioscience Holdings Ltd (RGC)2025-06-30-$3.77Mn/m
TFA Therapeutics, Inc. (RAJAF)2025-12-31-$141.1Kn/m
Functional Brands Inc. (MEHA)2025-12-31-$1.40Mn/m
Synergy CHC Corp. (SNYRQ)2025-12-31-$8.46Mn/m
Charlie's Holdings, Inc. (CHUC)2025-12-31-$2.17Mn/m
Cyanotech Corp (CYAN)2025-03-31-$2.51Mn/m
Mannatech Inc (MTEX)2025-12-31-$426.0Kn/m
Leef Brands Inc. (LEEEF)2025-12-31-$7.59Mn/m
Aibotics, Inc. (AIBT)2025-12-31-$1.84Mn/m

Compare RGC, RAJAF, MEHA, SNYRQ side by side · Screen every company in Medicinal Chemicals & Botanical Products ↗